Improving Outcomes of Patients with Heart Failure

0 reviews

Haymarket Medical Education

1 hour

PROGRAM DESCRIPTION
Heart failure (HF) is a complex progressive clinical condition that represents the end-stage of a range of cardiac diseases. It is associated with impaired physical functioning and vitality, decreased health-related quality of life (HRQOL), and mortality rates of nearly 50% within 5 years of diagnosis. Approximately 5.7 million US adults are affected by HF. The lifetime risk for developing HF among Americans ≥40 years of age has been estimated to be on the order of 20%. Because the incidence of HF increases with age, it is expected that the current epidemic will worsen over time given that 1 in 5 Americans will be >65 years of age by the year 2050. In addition to imposing a significant burden on affected individuals, HF also exerts a significant economic impact on the healthcare system. Hospital Medicine Summit (HMS) is an innovative, multi-topic educational initiative designed specifically for hospital-based healthcare providers (hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses). With significant changes occurring in the healthcare system, there is an increased demand on hospital-based healthcare providers to provide care that impacts patients not only in the acute setting, but as they transition back into the community and are managed in the chronic-care healthcare system.

EDUCATIONAL OBJECTIVES
Upon completion of this educational activity, participants should be able to:Outline an approach to the diagnosis and evaluation of patients with HF that is consistent with evidence-based guidelinesIdentify the mechanisms of action of new pharmacologic therapies for the treatment of heart failure with ejection fraction and describe the clinical evidence regarding their efficacy and safetyImplement guideline-directed medical therapy for patients with HFDescribe effective strategies for improving transitional care to achieve guideline-directed medical therapy and prevent future hospitalization of patients with HF